Biological age is the functional age of your cells and organs, which often differs from your chronological age (the number of years you have been alive). A 40-year-old can test with a biological age of 55 or as young as 28, depending on genetics, lifestyle, and environment. Scientists now measure it through several validated biomarker panels, with the most precise tools placing measurement error as low as plus or minus 2 to 3 years.
The Core Difference Between Chronological Age and Biological Age
Chronological age and biological age measure fundamentally different things. Chronological age simply counts the years since birth, while biological age reflects how efficiently your body’s systems are functioning relative to population norms for that calendar age.
Two people born on the same day can have biological ages that diverge by 10 to 20 years based on cumulative exposure to stress, diet quality, sleep, exercise habits, and environmental toxins. This divergence is not trivial. Research published in journals including Nature Aging and PNAS demonstrates that biological age is a significantly stronger predictor of mortality and chronic disease onset than chronological age alone.
Checkout our free online Age Calculator is calculated by counting the number of years, months and days completed since birth.
The distinction matters practically because health interventions that lower biological age, even modestly, have been linked to reduced all-cause mortality risk. A study in the Journals of Gerontology found that each one-year reduction in biological age was associated with a 2 to 3 percent decrease in mortality hazard.
How Biological Age Is Measured: The Major Methods
Scientists use several distinct approaches to calculate biological age. Each captures a different layer of the aging process.
| Method | What It Measures | Measurement Accuracy | Cost Range (U.S.) |
|---|---|---|---|
| Epigenetic clocks (DNA methylation) | Chemical tags on DNA that regulate gene expression | Plus or minus 2 to 4 years | $200 to $500 |
| Telomere length testing | Length of protective caps at chromosome ends | Moderate (high variability) | $100 to $300 |
| Blood biomarker panels (e.g., PhenoAge, BioAge) | Composite of routine lab values | Plus or minus 3 to 5 years | $50 to $150 |
| Proteomics (protein profiling) | Levels of thousands of circulating proteins | High (emerging gold standard) | $500 to $1,500+ |
| Composite indices (e.g., Klemera-Doubal Method) | Multiple physiological parameters combined | Plus or minus 3 to 6 years | $100 to $400 |
Each method has distinct strengths. Epigenetic clocks are currently the most validated for predicting mortality. Proteomics clocks, such as the SomaScan-based model published in Nature Aging in 2023, show extraordinary promise for capturing organ-specific aging rates.
Epigenetic Clocks: The Most Widely Validated Tool
Epigenetic clocks are the leading scientific method for measuring biological age, offering a level of precision that earlier biomarker approaches could not achieve. An epigenetic clock is a computational algorithm that reads the pattern of DNA methylation (a chemical process where methyl groups attach to specific sites on the DNA strand, switching genes on or off) across hundreds or thousands of genomic locations.
The first generation of epigenetic clocks was developed by Dr. Steve Horvath at UCLA. His 2013 Horvath Clock used 353 CpG sites (specific locations on the genome where methylation is measured) and could predict chronological age across multiple tissue types with impressive accuracy. It opened an entirely new chapter in aging science.
Subsequent clocks improved on this foundation:
- Hannum Clock (2013): Blood-specific, using 71 CpG sites, strong chronological age predictor.
- PhenoAge Clock (2018): Developed by Dr. Morgan Levine; trained to predict mortality rather than chronological age, making it clinically more powerful.
- GrimAge Clock (2019): Incorporates smoking exposure and plasma protein proxies; one of the strongest predictors of lifespan and healthspan in the published literature.
- DunedinPACE (2022): Measures the rate of aging rather than a static age estimate; derived from longitudinal data in the Dunedin cohort study in New Zealand.
- ClockDNA / commercial variants: Consumer-facing versions now available through companies including TruDiagnostic, Elysium Health, and Biological Age Test providers, ranging from $200 to $500 per test.
GrimAge and DunedinPACE are currently considered the most predictively powerful clocks for health outcomes among researchers. A 10-unit increase in GrimAge acceleration has been associated with a more than twofold increase in mortality risk in several prospective cohort studies.
Blood Biomarker Panels: Accessible and Clinically Practical
Blood biomarker panels give clinicians and individuals a practical, affordable route to estimating biological age without requiring specialized genetic sequencing. These panels aggregate routine lab values into a composite biological age score.
PhenoAge, developed by Drs. Levine and Belsky, uses nine blood markers to calculate biological age:
- Albumin (protein levels indicating nutritional and liver status)
- Creatinine (kidney filtration efficiency)
- Glucose (blood sugar regulation)
- C-reactive protein (a marker of systemic inflammation)
- Lymphocyte percentage (immune competence indicator)
- Mean corpuscular volume (red blood cell size, related to B-vitamin status)
- Red cell distribution width (variability in red blood cell size)
- Alkaline phosphatase (liver and bone enzyme)
- White blood cell count (immune system activity level)
An individual whose composite PhenoAge score is 5 or more years above their chronological age is considered to be aging acceleratedly by this measure. Conversely, a PhenoAge score 5 or more years below chronological age is associated with meaningfully lower disease risk and longer expected healthspan.
These panels are often included in standard metabolic blood work, making them accessible through a primary care physician or through direct-to-consumer lab services at costs as low as $50 to $150 depending on the panel breadth.
Telomere Length: A Popular but Imprecise Indicator
Telomere length is one of the oldest and most widely recognized biological aging markers, though modern research has tempered early enthusiasm about its standalone diagnostic power. Telomeres are repetitive DNA sequences (the sequence TTAGGG repeated thousands of times) that cap the ends of chromosomes, much like the plastic tips on shoelaces, protecting genetic material from degradation during cell division.
With each cell division, telomeres shorten by roughly 50 to 200 base pairs (units of DNA length). When telomeres become critically short, cells enter a state called senescence (a permanent state of growth arrest in which the cell can no longer divide but remains metabolically active and often pro-inflammatory) or undergo apoptosis (programmed cell death).
People with shorter telomeres for their age show elevated risk for cardiovascular disease, type 2 diabetes, and certain cancers. A landmark study in The Lancet found that individuals in the lowest quartile of telomere length had a 3-fold higher risk of heart disease compared to those in the highest quartile.
However, telomere length testing shows high biological variability even within the same individual, tested repeatedly on the same day. For this reason, most aging researchers currently use telomere length as one component of a multi-biomarker panel rather than as a standalone biological age calculator.
Proteomics: The Emerging Frontier
Protein-based aging clocks are rapidly gaining recognition as perhaps the most informative biological age tools yet developed. Proteomics refers to the large-scale study of all proteins present in a biological sample, typically blood plasma, at a given time.
In 2023, a research team at Stanford published a study in Nature Aging showing that plasma proteins cluster into distinct aging patterns across 11 major organs, including the heart, brain, liver, kidney, and immune system. This organ-specific aging approach revealed something genuinely fascinating: different organs within the same person can age at dramatically different rates.
The SomaScan platform, developed by SomaLogic, can measure approximately 7,000 proteins from a single blood draw. Applying machine learning to this data, researchers developed organ-specific aging clocks that predict organ dysfunction years before clinical symptoms emerge. A person might have a cardiovascular system 15 years older than their chronological age while their brain age tracks 5 years younger, a profile with very specific health implications.
These tests are currently priced between $500 and $1,500+ and are not yet standard clinical practice in the United States, but several biotech companies including Alkahest and Juvena Therapeutics are working to translate proteomics research into accessible diagnostics and therapeutics.
What Factors Actually Accelerate or Decelerate Biological Aging?
Research has identified specific modifiable behaviors and exposures that meaningfully shift biological age measurements. The factors below are ranked by strength of evidence in peer-reviewed literature.
| Factor | Direction of Effect | Estimated Biological Age Impact |
|---|---|---|
| Smoking (current, heavy) | Accelerates | +4 to +7 years on GrimAge |
| Obesity (BMI over 30) | Accelerates | +2 to +5 years on multiple clocks |
| Chronic sleep deprivation (under 6 hours) | Accelerates | +1.5 to +3 years |
| High ultra-processed food intake | Accelerates | +1 to +4 years |
| Chronic psychological stress | Accelerates | +2 to +4 years |
| Regular aerobic exercise (150+ min/week) | Decelerates | -1 to -3 years |
| Mediterranean-style diet adherence | Decelerates | -1.5 to -3.5 years |
| Caloric restriction / time-restricted eating | Decelerates | -0.5 to -2.5 years (emerging evidence) |
| High-quality sleep (7 to 9 hours) | Decelerates | -1 to -2 years |
| Non-smoking status maintained long-term | Decelerates relative to smokers | +3 to +6 years better than continuing smokers |
A landmark clinical trial called CALERIE (Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy) demonstrated that a 12 percent caloric restriction over two years produced a statistically significant slowing of the DunedinPACE aging rate in healthy adults, providing some of the first controlled human evidence that biological aging rate is modifiable.
Biological Age in Clinical Medicine: Where It Stands Today
Biological age testing is not yet a standard component of routine clinical care in the United States, though adoption is growing rapidly in the longevity medicine and preventive health sectors. Several practical barriers still limit mainstream clinical use.
Insurance coverage for dedicated biological age panels is currently limited. Most epigenetic clock tests and advanced proteomics panels are paid out-of-pocket, ranging from $200 to $1,500 depending on complexity. Routine PhenoAge-style panels derived from standard lab work may be covered as part of comprehensive metabolic panels under certain insurance plans.
Regulatory status also plays a role. The FDA has not yet formally approved any biological age test as a diagnostic device, meaning results are intended for informational and research purposes rather than definitive diagnosis. Several companies market their tests as wellness tools operating under this framework.
Despite these limitations, biological age data is increasingly informing clinical decisions in functional medicine, corporate wellness programs, and life insurance underwriting research. A growing number of longevity-focused physicians, including practitioners at organizations like the American Academy of Anti-Aging Medicine, now incorporate epigenetic clock testing into patient workups as a motivational and monitoring tool.
How Reliable Are Biological Age Tests?
The reliability of biological age tests varies meaningfully by method and depends on several technical and biological factors. Understanding test-retest reliability is essential before interpreting any single measurement.
Epigenetic clocks show strong test-retest reliability when the same tissue type is used and laboratory protocols are standardized. Studies show intraclass correlation coefficients above 0.90 for leading clocks like GrimAge when conditions are controlled, meaning results are highly consistent across repeated measurements in stable conditions.
Telomere length tests show more variability. Studies have documented 5 to 15 percent intra-individual variability in telomere measurements even within a short time window, partially because telomere length differs between tissue types and even between cells within the same tissue.
Blood biomarker panels like PhenoAge are subject to short-term fluctuations driven by recent illness, dehydration, medication use, and timing relative to meals. For accurate baseline measurement, most protocols recommend fasting blood draws taken during a period of stable health, avoiding testing within 4 weeks of significant illness or surgery.
Proteomics platforms such as SomaScan show high analytical precision but remain subject to pre-analytical variability (differences in how blood is collected, stored, and processed before testing). Leading commercial labs now publish detailed handling protocols to minimize this source of error.
The Science of Slowing Biological Age: What the Research Shows
The possibility of meaningfully reversing biological age captured significant scientific attention after a 2019 pilot study by Dr. Gregory Fahy and colleagues found that a nine-month protocol combining recombinant human growth hormone, metformin (a diabetes medication used here for its proposed anti-aging properties), and DHEA (a hormone precursor) produced an average 2.5-year reduction in epigenetic age across nine male participants. Though small, the study was published in Aging Cell and was the first to demonstrate a measurable reversal of an epigenetic clock in humans under a controlled intervention.
More recently, the TRIIM-X trial expanded on these findings with a larger cohort and similar results. Simultaneously, the field of senolytics (drugs designed to selectively clear senescent cells from the body, removing the pro-inflammatory “zombie cells” that accumulate with age) has produced promising early human trials. Dasatinib combined with quercetin, two of the most studied senolytics, showed reductions in senescent cell burden and improvements in physical function in Phase 1 and Phase 2 trials at the Mayo Clinic.
Rapamycin (an immunosuppressant drug that inhibits the mTOR pathway, a key cellular nutrient-sensing and growth-regulation mechanism), caloric restriction mimetics, and NAD+ precursors including nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are all under active clinical investigation for their effects on epigenetic and other biological aging clocks in the United States. Results to date are preliminary but meaningfully encouraging.
Consumer Testing Options in the United States
Americans interested in testing their biological age have several accessible commercial options, ranging from budget-friendly blood panels to comprehensive multi-clock epigenetic analyses.
| Company/Service | Method Used | Price Range | Turnaround Time |
|---|---|---|---|
| TruDiagnostic | Epigenetic (multiple clocks including DunedinPACE) | $299 to $599 | 3 to 4 weeks |
| Elysium Index | Epigenetic (proprietary clock) | $299 per test | 4 to 6 weeks |
| Inside Tracker | Blood biomarkers (PhenoAge-adjacent) | $149 to $699 | 1 to 2 weeks |
| LabCorp / Quest Diagnostics | Routine metabolic panels (PhenoAge calculable from results) | $50 to $150 | 3 to 7 days |
| Juvenescence / Atome | Proteomics (emerging) | $800 to $1,500+ | 4 to 8 weeks |
| Life Length | Telomere length | $100 to $300 | 3 to 5 weeks |
Several free online calculators (including the PhenoAge calculator published by researchers at Yale) allow individuals to compute their PhenoAge from standard lab values already in hand, making entry-level biological age assessment accessible at no additional cost beyond standard blood work.
The Future of Biological Age Science
Biological age research is advancing at a genuinely remarkable pace, driven by intersecting progress in genomics, machine learning, and longitudinal population studies. Several directions are expected to transform the field significantly within the next decade.
Single-cell aging clocks are being developed to assess biological age at the resolution of individual cell types, potentially revealing aging patterns invisible to bulk tissue measurements. Continuous biological age monitoring through wearables that track physiological proxies in real time is an active area of research and commercial development, with companies including Whoop and Oura already publishing data on physiological age proxies derived from heart rate variability and sleep architecture.
The NIH-funded Biomarkers of Aging Consortium is working to establish consensus standards for biological age measurement, which would allow results from different platforms and laboratories to be meaningfully compared, a capability the field currently lacks. Standardization will be a critical step toward FDA approval and insurance coverage.
Perhaps most ambitiously, the concept of epigenetic reprogramming (partially resetting the epigenome of aged cells to a more youthful state using transcription factors) is being explored by companies including Altos Labs, which has raised more than $3 billion in funding, and by academic labs at Harvard and the Salk Institute. If successful in humans, epigenetic reprogramming would represent not a slowing of biological aging but a measurable reversal, a genuinely transformative prospect for medicine.
Frequently Asked Questions
What is biological age in simple terms?
Biological age is a measure of how old your body’s cells and systems function compared to the average for people your chronological age. A person who is 45 years old chronologically might have a biological age of 38 if their biomarkers, DNA methylation patterns, and organ function align with a healthier, younger population average. It is distinct from the number of years you have lived.
What is the most accurate test for biological age?
Epigenetic clocks, particularly GrimAge and DunedinPACE, are currently considered the most accurate and predictive biological age tests available. These tests analyze DNA methylation patterns from a blood sample and have been validated in large population studies to predict mortality and disease risk more accurately than chronological age. Proteomics-based clocks are emerging as potentially even more precise.
Can you reverse your biological age?
Early clinical evidence suggests biological age can be partially reversed or at least slowed through targeted interventions. A 2019 pilot trial showed an average 2.5-year epigenetic age reduction using a combination of growth hormone, metformin, and DHEA over nine months. Lifestyle changes including consistent aerobic exercise, high-quality sleep, and dietary improvements have also been shown to reduce biological age markers in multiple controlled studies.
How much does a biological age test cost in the U.S.?
Biological age tests in the United States range from approximately $50 for a standard blood panel that can be used to calculate PhenoAge, to $299 to $599 for commercial epigenetic clock tests, to $800 to $1,500+ for advanced proteomics panels. Most dedicated biological age tests are not currently covered by health insurance and are paid out-of-pocket.
What lifestyle factors age you the fastest biologically?
Smoking is the single lifestyle factor most consistently associated with accelerated biological aging across epigenetic clock studies, adding an estimated 4 to 7 years to GrimAge scores in heavy long-term smokers. Obesity, chronic sleep deprivation under 6 hours per night, high intake of ultra-processed foods, and sustained psychological stress each independently contribute 1 to 5 years of additional biological aging across validated measurement tools.
Is biological age the same as cellular age?
Biological age and cellular age are closely related but not identical terms. Biological age typically refers to a composite measure derived from multiple biomarkers across many body systems. Cellular age can refer more specifically to the replicative history of individual cells, often gauged by telomere length or the accumulation of senescent cells. Most modern biological age tests integrate both cellular and systemic markers to produce a single score.
What does it mean if your biological age is higher than your actual age?
If your biological age is higher than your chronological age, your body’s cells and systems are functioning as though they belong to an older person than you are. This state, called accelerated aging in the research literature, is associated with elevated risk of cardiovascular disease, type 2 diabetes, cognitive decline, and earlier all-cause mortality. It does not mean disease is inevitable, and multiple lifestyle and, in some cases, pharmaceutical interventions have been shown to reduce accelerated biological age scores.
How often should you test your biological age?
Most researchers and clinicians in the longevity field recommend testing biological age no more frequently than once every 6 to 12 months when tracking the effects of a specific intervention, or annually for general health monitoring. Testing too frequently can create misleading short-term noise because many biomarkers fluctuate based on recent illness, stress, or lifestyle events that do not reflect true long-term aging trajectory.